Physician profile
David W Marsh
NPI 1548359417
$2,005.65
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2021: $69.44 · 2022: $1,778 · 2023: $54.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $871.03 | 2022 | |
| Boston Scientific Corporation | $129.25 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $96.45 | 2022 | |
| Endo Pharmaceuticals INC. | $86.73 | 2022 | |
| Myovant Sciences INC. | $81.14 | 2022 | |
| Abbvie INC. | $80.49 | 2022 | |
| Teleflex LLC | $71.39 | 2022 | |
| Urogen Pharma, INC. | $54.46 | 2022 | |
| Astellas Pharma US INC | $53.56 | 2022-2023 | Xtandi |
| Karl Storz Endoscopy-America | $50.34 | 2021 | |
| Janssen Biotech, INC. | $48.61 | 2022-2023 | Erleada |
| Accord Healthcare, INC. | $48.27 | 2022 | |
| Merck Sharp & Dohme LLC | $44.00 | 2022 | |
| Rochester Medical Corporation | $35.52 | 2022 | |
| Emd Serono, INC. | $33.01 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $32.83 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $30.20 | 2022 | |
| Sun Pharmaceutical Industries INC. | $23.93 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $21.02 | 2023 | Bard Urinary Drainage Bag |
| Cook Medical LLC | $19.10 | 2021 | |
| Amgen INC. | $18.68 | 2022 | |
| Verity Pharmaceuticals INC. | $17.62 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.88 | 2022 | |
| Antares Pharma, INC. | $15.84 | 2022 | |
| Coloplast Corp | $13.10 | 2022 | |
| 180 Medical, INC. | $12.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Marsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.